Related Experiment Video

Updated: Aug 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Hepatitis and transfusions

K Donnelly1

  • 1U.S. Army Reserve, Lindenhurst, NY, USA.

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
|May 3, 2006
PubMed

Insights

Hepatitis B and C viruses (HBV and HCV) cause significant liver disease, including cancer. Medical procedures may transmit these bloodborne pathogens, with hemodialysis being a notable risk factor for HCV infection.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are leading causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC).
  • Concerns exist regarding the nosocomial transmission of bloodborne pathogens, including HIV, HBV, and HCV, during medical procedures.
  • Hepatitis viruses, particularly HBV and HCV, are more prevalent than HIV and pose a significant public health threat.

Purpose of the Study:

  • To highlight the risk of bloodborne pathogen transmission during medical procedures.
  • To emphasize the prevalence and impact of HBV and HCV infections.
  • To investigate the role of hemodialysis as a risk factor for HCV infection.

Main Methods:

  • Review of existing literature on HBV and HCV transmission.
  • Analysis of data concerning bloodborne pathogen transmission in healthcare settings.
  • Evaluation of epidemiological evidence linking hemodialysis to HCV infection.

Main Results:

  • HBV and HCV are major contributors to liver disease globally.
  • Chronic HBV and HCV infections can progress to cirrhosis and HCC.
  • Circumstantial evidence indicates hemodialysis is a significant risk factor for HCV acquisition.

Conclusions:

  • Healthcare-associated transmission of HBV and HCV is a serious concern.
  • Increased vigilance is needed to prevent HBV and HCV spread during medical interventions.
  • Hemodialysis patients require specific attention to mitigate HCV transmission risks.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...